Semaglutide has been in clinical use since 2017 for diabetes and since 2021 for weight management
Al-Sabah S, and Donnelly D
109.3 Comparative performance of the EQ-5D-5L and PROMIS-10 in the elderly: Data from the EQ-DAPHNIE project in five countries Thao Nguyen 1 , Arto Ohinmaa 1 , Hilary Short 1 , Fatima Al Sayah 1 1 Alberta PROMs and EQ-5D Research and Support Unit (APERSU) School of Public Health, University of Alberta, Edmonton, Alberta, Canada Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :109.3 Aims This study compared the performance of the EQ-5D-5L and PROMIS-10 in measuring health-related quality of life (HRQL) among older adults in five English-speaking countries
Wegovy is approved for people with a: BMI of 30 or higher
In contrast, standard dosing is approved by the FDA and supported by the various clinical trials, while microdosing is not FDA-approved
Patients commonly present with pain, tenderness, easy bruising, and progressive swelling that spares the feet, creating a characteristic "cuff" appearance at the ankles
